Table 1 Sample characteristics overall and by male/female sex (N=819)
From: Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer
Characteristic | Total (N = 819) | Men (N = 389) | Women (N = 430) |
|---|---|---|---|
Age, mean ± SD, y | 58.5 ± 11.8 | 61.4 ± 10.8 | 55.9 ± 12.2 |
Age group, No. (%) | |||
≤ 40 years | 59 (7) | 14 (4) | 45 (10) |
41 to 50 years | 127 (16) | 29 (7) | 98 (23) |
51 to 64 years | 377 (46) | 197 (51) | 180 (42) |
65 to 79 years | 232 (28) | 134 (35) | 98 (23) |
≥ 80 years | 21 (3) | 13 (3) | 8 (2) |
Race, No. (%) | |||
Black or African American | 80 (10) | 39 (10) | 41 (10) |
American Indian/Alaska Native | 10 (1) | 6 (2) | 4 (<1) |
Asian | 12 (1) | 2 (<1) | 10 (2) |
Native Hawaiian/Other Pacific Islander | 2 (<1) | 1 (<1) | 1 (<1) |
White | 705 (87) | 338 (87) | 367 (86) |
Multiple races or other | 6 (<1) | 1 (<1) | 5 (<1) |
Hispanic or Latino ethnicity, No. (%) | 21 (3) | 10 (3) | 11 ( 3) |
Educational attainment, No. (%) | |||
Less than high school | 24 (3) | 14 (4) | 10 ( 2) |
High school graduate/GED | 100 (12) | 35 (9) | 65 (15) |
Some college | 255 (31) | 122 (31) | 133 (31) |
College degree | 229 (28) | 114 (29) | 115 (27) |
Advanced degree (MA, PhD, MD) | 211 (26) | 104 (27) | 107 (25) |
Treatment status in past month, No. (%) | |||
None (ie, posttreatment follow-up) | 526 (64) | 290 (75) | 236 (55) |
Undergoing treatment | 290 (36) | 98 (25) | 192 (45) |
Radiation therapy | 29 (4) | 15 (4) | 14 (3) |
Hormonal therapy (eg, tamoxifen, anastrozole, leuprolide) | 140 (17) | 28 (7) | 112 (26) |
Chemotherapy (injection or oral) | 116 (14) | 46 (12) | 70 (16) |
Immunotherapy (eg, interferon) | 9 (1) | 2 (<1) | 7 (2) |
Other | 36 (4) | 17 (4) | 19 (4) |
Recurrence of cancer, No. (%) | 151 (18) | 68 (17) | 83 (19) |
Cancer spread to lymph nodes, No. (%) | 202 (25) | 68 (17) | 134 (31) |
Cancer spread to another area, No. (%) | 134 (16) | 57 (15) | 77 (18) |
Primary cancer diagnosis, No. (%) | |||
Breast cancer | 252 (35) | 1 (<1) | 251 (62) |
Colorectal | 98(13) | 57 (18) | 41 (10) |
Gynecologic cancer | 29 (4) | – | 29 (7) |
Lung cancer | 56 (8) | 35 (11) | 21 (5) |
Prostate cancer | 146 (20) | 146 (45) | – |
Other or Unknown | 9 (1) | 6 (2) | 3 (<1) |